Self-propelled actin filaments: Novel structures driving spontaneous cell morphogenesis
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
-
-
Colossal Biosciences and US Fish and Wildlife Service Partner to Biobank Every Endangered Species
On Jun. 25, 2026, Colossal Biosciences US Fish and Wildlife Service announced a partnership that aims to collect…
-
In shift, Pentagon grants flu vaccine exceptions to military services, some federal agencies
On Jun. 24, 2026, the Pentagon announced it has updated the guidance on the influenza vaccination, offering exceptions…
-
Antares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
-
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
-
high-endurance DNA origami snap-through switch for functional nanoscale control
On Jun. 24, 2026, researchers from the Technical University of Munich presented a DNA origami–based, mechanically bistable snap-through…
-
Nanoparticles sneak antibodies into cells to inhibit cancer, inflammation
On Jun. 23. 2026, scientists at Cornell University announce discovering a delivery system that uses lipid nanoparticles to…
-
Contagious Cancer Likely Crossed an Ocean, Triggering Severe Outbreak in Pacific Northwest Clams
On Jun. 23, 2026 – researchers from the Pacific Northwest Research Institute in Seattle announced they have identified…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | NIH | Therapeutics | Vaccine | WHO
US provides Ebola treatment for outbreak in Congo, bringing trials closer
On Jun. 23, 2026, the U.S. has provided doses of an experimental antibody drug from Mapp Biopharmaceutical for…
-
Manning Family Children’s makes history as Louisiana’s first Sickle Cell Disease gene therapy marking his functional cure
On Jun. 22, 2026, Louisiana’s first Sickle Cell Disease gene therapy patient is now set to pursue his…
-
Flu outbreak sickens 200 trainees at Lackland Air Force Base
On Jun. 22, 2026. The Air Force announced that more than 200 service members at a Texas base…
-
FDA to launch pilot program to speed up early-stage clinical trials
On Jun. 22, 2026, Federal health officials announced a pilot program Monday to speed up early-stage clinical trials,…
-
Cancer-on-a-chip pioneer Chen Weiqiang returns to China from New York University
On Jun. 21, 2026, Chen Weiqiang, formerly a tenured professor of mechanical and biomedical engineering at New York…
-
Project Launched on Use of Nuclear Technique to Target New World Screwworm Outbreak in Central America, Mexico and the United States
On Jun. 19, 2026, the International Atomic Energy Agency (IAEA) and Food and Agriculture Organization of the United…
-
USC Stem Cell-led team creates a renewable cell source for cancer immunotherapy and beyond
On Jun. 19, 2026, University of Southern California (USC) scientists report in a paper published in Cell, a…
-
FDA panel backs first-of-its-kind flu vaccine using mRNA technology
On Jun. 18, 2026, a new kind of flu vaccine moved a step closer to the U.S. market…
-
Ancient teeth from Siberia rewrite the plague’s timeline, dating back to over 5,500 years ago
On Jun. 17, 2026, scientists announced they have have found the oldest known evidence of the plague, which…
-
An experimental molecule “reprograms” the brain’s defenses against Alzheimer’s disease
On Jun. 17, 2026, a team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences…
-
Harvard-led team Makes DNA on a Semiconductor Chip
On Jun. 17, 2026, Harvard researchers announced setting a new benchmark for enzymatic DNA synthesis by writing 64…
-
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera for $1 Billion
On Jun. 17, 2026, Biogen and RayThera, a private biotechnology company focused on discovering and developing small molecule…
-
FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose
On Jun. 16, 2026, the U.S. Food and Drug Administration (FDA) approved another over-the-counter (OTC) intranasal naloxone product,…
-
Protillion Biosciences Signs Drug Discovery Collaboration with Merck Worth $510 Million
On Jun. 16, 2026, Protillion Biosciences, a leader in lab-in-the-loop AI drug design,announced the signing of a multi-target…
-
USDA Invests in Projects to Strengthen New World Screwworm Preparedness and Response
On Jun. 16, 2026, the U.S. Department of Agriculture (USDA) is announcing funding for 40 breakthrough projects to…
-
Joint Service Program Delivers Genetic sequencing technology to the Modern Battlefield
On Jun. 12, 2026, the U.S. Naval Research Laboratory (NRL), in partnership with the Defense Threat Reduction Agency…
-
Biotechnology | Disease | NIH | Therapeutics
University of Oklahoma Receives $11.5 Million NIH Award to Establish Statewide Immunoengineering Research Center
On Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from…
-
FDA Issues EUA for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats
On Jun. 11, 2026, The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for generic…
-
the American College of Obstetricians & Gynecologists released its 2026 maternal immunization schedule
On Jun. 10, 2026, the American College of Obstetricians & Gynecologists (ACOG) released its 2026 maternal immunization schedule….
-
FDA Expands Sunscreen Options for the First Time in 20 Years
On Jun. 9, 2026, the U.S. Food and Drug Administration (FDA) announced it has added bemotrizinol to the…
-
China performs world’s first combined transplant of pig liver and kidney to human
On Jun. 9, 2026, Chinese surgeons announced they have carried out the world’s first combined transplant of a…
-
GSK enters agreement to acquire Nuvalent for $10.6 Billion
On Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage…
